/ETON

Eton Pharmaceuticals Inc

ETON

$57.08USD↓-1.38%-0.80 today

MARKET CAP

1.6B

P/E (TTM)

—

FWD P/E

—

DAY RANGE

$56 – $60

52W RANGE

$14

$66

AI Summary

Stalk

Buy NowMedium

ETON has pulled back into the confluence of its rising 9 and 20 EMAs near prior support, where a Bearish Exhaustion inflection signals seller fatigue and increases the probability of a reversal bounce. The medium-term uptrend remains intact with higher highs and lows supported by the 50 DMA, while RSI retracement into near-oversold territory aligns short-term timing for a rebound. We recommend initiating long positions now at the EMA support zone with focus on price acceptance above this level.

↑Q2 revenue climbed 99% YoY to $37.6M, driving record top-line growth.
↑Management upped full-year 2026 revenue forecast from $120M to >$145M.
↓Negative earnings yield and weak book-to-price raise valuation red flags.

Full analysis →

Buying

4

institutions

Selling

5

institutions

New Positions

2

this quarter

Filing Period

Q2 2026

latest 13-F

13-F Holdings

Institution↕	Action↕	Shares Held↕	Value↓	Change↕	Chg %↕	Weight↕
BI Blackrock, Inc. Q2 2026	BUY	1.90 M	68.63 M	+178.55 K	+61.9%	0.00%
WP Woodline Partners LP Q2 2026	SELL	310.88 K	11.25 M	+-30.52 K	+33.6%	0.03%
JC Jpmorgan Chase & Co Q2 2026	BUY	191.63 K	7.04 M	+21.76 K	+83.5%	0.00%
CA Citadel Advisors LLC Q2 2026	SELL	85.37 K	3.09 M	+-66.35 K	-17.5%	0.00%
RT Renaissance Technologies LLC Q2 2026	SELL	52.30 K	1.89 M	+-111.02 K	-53.0%	0.00%
PA Point72 Asset Management, L.P. Q2 2026	BUYNEW	44.92 K	1.63 M	+44.92 K	+0.0%	0.00%
MG Man Group Plc Q2 2026	BUYNEW	16.15 K	584.70 K	+16.15 K	+0.0%	0.00%
BH Brevan Howard Capital Management LP Q2 2026	SELL	7.96 K	287.97 K	+-14.55 K	-48.2%	0.00%
MM Millennium Management LLC Q2 2026	SELL	0.00	0.00	+-14.94 K	-100.0%	0.00%